All ears about all things, #IoT,#AI,#Healthcare .Deep domain customer facing experience & ahimsa aligned. Views are my own; likes & R/T, not endorsement.
Roeker et al. MRD guided duration of ven + obin in previously untx CLL. 90% of pts with high pre tx TLS converted to low or medium risk following obin cycle 1. Ven can be administered in outpt setting with close monitoring regardless of TLS risk. @LRoekerMD@MSKCancerCenter
Congrats! Dr. Rachna T. Shroff (@rachnatshroff), professor of medicine in the @UAZMedTucson and chief of the @UAZHemeOnc, named Woman Disruptor of the Year by Healio during the @ASCO Annual Meeting in June. She also was inducted as a fellow by @ASCO. More: https://t.co/hFmWFilqXi
Standing in for the irreplaceable @tobyeyre82 sharing our work on patients on cBTKi who dc due to reasons other than PD (primarily intolerance). Both cBTKi and ven work but our data favors ven by ORR and PFS #iwCLL23
By leveraging cutting-edge tech, data security measures &patient-centric approach, we at @HospitalsApollo Telehealth are working towards creating a world where qty healthcare knows no bounds
Over the next decade I foresee a quantum leap in healthcare access facilitated by tech
Exciting data in #CLL presented at #EHA2023 this year! Register for #iwCLL2023 and join international leaders in the field to discuss updates in the #CLL treatment landscape.
For additional program details & updates, visit https://t.co/VlC6sQj0KwExciting data in #CLL presented at #EHA2023 this year! Register for #iwCLL2023 and join international leaders in the field to discuss updates in the #CLL treatment landscape.
For additional program details & updates, visit https://t.co/VlC6sQj0KwExciting data in #CLL presented at #EHA2023 this year! Register for #iwCLL2023 and join international leaders in the field to discuss updates in the #CLL treatment landscape.
For additional program details & updates, visit https://t.co/VlC6sQj0KwExciting data in #CLL presented at #EHA2023 this year! Register for #iwCLL2023 and join international leaders in the field to discuss updates in the #CLL treatment landscape.
For additional program details & updates, visit https://t.co/VlC6sQj0KwExciting data in #CLL presented at #EHA2023 this year! Register for #iwCLL2023 and join international leaders in the field to discuss updates in the #CLL treatment landscape.
For additional program details & updates, visit https://t.co/VlC6sQj0Kw.
Congratulations @mshadman@fredhutch for this comprehensive yet concise overview of CLL in @JAMA_current -- great article to send to new fellows joining me in clinic so they can read up ahead of time! https://t.co/peYCbi81jr
@NYCFireWire Bless the brave FDNY for putting this fire out. My home on the third floor of a neighboring building(2279 3rd ave) was impacted and rendered uninhabitable for the remainder of 2023. Thank god my tenants weren't hurt.
Impressive work and vision at the @btfoundation led by @binayshah and team in improving access to cancer therapies and care around the world.
Great to be at #btfash and looking forward to attending #btfschd23
Such an important cause to support!
What are your hopes for the new year? Sandy Wong, MD, @SandyWong02111, shares her hopes for the new year as a as a clinician and researcher in this video.
https://t.co/tRmrdNq5a4
The @StanfordMed Hematology Division is hiring a new Chair. A truly enormous opportunity to join and lead an incredible group of people! @StanfordCancer https://t.co/XbiW6LiUmQ